Matthew Hewitt, PhD.

Manufacturing and Strategic Advisor

Matthew leverages a PhD in Immunology and 10+ years of experience as Vice President and Technical Officer of Cell and Gene Therapy (CGT) and Biologics at Charles River Laboratories (CRL) leading multiple initiatives across Charles River’s CGT portfolio, including a CGT CDMO. Before CRL, Matt was Head of Clinical Development for Lonza’s Personalized Medicine Business Unit where he played a key role in accelerating clinical development timelines all while overseeing numerous academic and industry collaborations.